Anidulafungin en es it fr

Anidulafungin Brand names, Anidulafungin Analogs

Anidulafungin Brand Names Mixture

  • No information avaliable

Anidulafungin Chemical_Formula


Anidulafungin RX_link

No information avaliable

Anidulafungin fda sheet

Anidulafungin msds (material safety sheet)

Anidulafungin Synthesis Reference

No information avaliable

Anidulafungin Molecular Weight

1140.24 g/mol

Anidulafungin Melting Point

No information avaliable

Anidulafungin H2O Solubility

Practically insoluble

Anidulafungin State


Anidulafungin LogP


Anidulafungin Dosage Forms

Injection (50 mg vials to be reconstituted prior to injection)

Anidulafungin Indication

For use in the treatment of the following fungal infections: Candidemia and other forms of Candida infections (intra-abdominal abscess, and peritonitis) and esophageal candidiasis.

Anidulafungin Pharmacology

Anidulafungin is a semi-synthetic lipopeptide synthesized from a fermentation product of Aspergillus nidulans. Anidulafungin is an echinocandin, a class of antifungal drugs that inhibits the synthesis of 1,3-β-D-glucan, an essential component of fungal cell walls. Anidulafungin is active in vitro against Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis.

Anidulafungin Absorption

No information avaliable

Anidulafungin side effects and Toxicity

During clinical trials a single 400 mg dose of anidulafungin was inadvertently administered as a loading dose. No clinical adverse events were reported. The maximum non-lethal dose of anidulafungin in rats was 50 mg/kg, a dose which is equivalent to 10 times the recommended daily dose for esophageal candidiasis (50mg/day).

Anidulafungin Patient Information

Anidulafungin Organisms Affected

Aspergillis, Candida and other fungi